Latest news
IDEAYA Biosciences (IDYA) Stock Could Be Fully Valued After Trial Progress - simplywall.stsimplywall.st · Thu, 06 Aug 2026 16:35:29 GMTHow Beam’s Wider Q2 Loss and Trial Progress Will Impact Beam Therapeutics (BEAM) Investors - simplywall.stsimplywall.st · Thu, 06 Aug 2026 14:40:00 GMTArrowhead Pharmaceuticals (ARWR) Could Be 3% Undervalued On Late Stage Trial Progress - simplywall.stsimplywall.st · Thu, 30 Jul 2026 07:00:00 GMT